首页>
外国专利>
APPLICATION OF A COMPOSITION FOR REDUCING PROGRESSION AND REDUCING ADVERSE EFFECTS IN PATIENTS WITH DEMYELINIZING DISEASES SPECIALLY MULTIPLE SCLEROSIS
APPLICATION OF A COMPOSITION FOR REDUCING PROGRESSION AND REDUCING ADVERSE EFFECTS IN PATIENTS WITH DEMYELINIZING DISEASES SPECIALLY MULTIPLE SCLEROSIS
展开▼
机译:一种组合物在减少多发性骨髓炎特别是多发性硬化症患者中的进展和减轻不良反应的应用
展开▼
页面导航
摘要
著录项
相似文献
摘要
The use of a composition to reduce progression and reduce adverse effects in patients with demyelinating diseases, especially multiple sclerosis, refers to enhanced treatment and an increase in the dose of the supplement consisting of: L-Carnosine (10-90%, best 55.5%), D-alpha - tocopherol succinate (1-18%, best 8,88%), L-carnitine tartrate (1-18%, best 8,88%), coenzyme Q10 (1-18%, best 8,88%), dry extract northern blueberry fruit (1-18%, best 8,88%), dry grape seed extract (1-18%, best 8,88%), with L-carnosine values 750 mg, and for all other components 120 mg daily, resulting in an unexpected positive effect expressed through reducing demyelination and improving neurological symptoms, whereby no such adverse effects are produced during such enhanced treatment, and efficacy has been established even in cases of severe progressive demyelinating diseases.
展开▼